P3 Health Partners Inc (PIII)

Currency in USD
10.4900
+1.3200(+14.39%)
Closed·
10.0000-0.4900(-4.67%)
·
Unusual trading volume
PIII is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.350013.1000
52 wk Range
1.520014.3500
Key Statistics
Prev. Close
10.49
Open
10.06
Day's Range
9.35-13.1
52 wk Range
1.52-14.35
Volume
3.43M
Average Volume (3m)
1.23M
1-Year Change
30.4726%
Book Value / Share
-43.99
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PIII Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.5000
Downside
-18.97%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

P3 Health Partners Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 8.5000
(-18.97% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Lake Street
Buy14.00+33.46%4.00Maintain15-05-2026
TD Cowen
Hold3.00-71.40%8.00Maintain02-04-2026
Lake Street
Buy4.00-61.87%12.50Maintain27-03-2026
Lake Street Capital Markets
Buy12.50+19.16%20.00Maintain17-11-2025
Lake Street Capital Markets
Buy20.00+90.66%-New Coverage28-08-2025

P3 Health Partners Inc Earnings Call Summary for Q1/2026

  • P3 Health Partners posted Q1 2026 adjusted EBITDA of $26M vs. $22M loss year-ago, a $48M improvement; revenue rose 3.5% to $386M.
  • Stock surged 14.39% to $10.49 post-earnings, up 194% weekly and 200%+ YTD following debt restructuring converting $250M to preferred equity.
  • Company forecasts EPS of $4.92 by FY2027 with revenue reaching $1.64B, driven by strategic portfolio optimization and cost management.
  • At-risk membership declined to 106K from 118K, offset by improved per-member Medicare Advantage funding and operational efficiency gains.
  • Executives attribute turnaround to structural competitive advantages and deliberate actions, though regulatory changes and medical cost trends pose risks.
Last Updated: 20-05-2026, 01:34 pm
Read Full Transcript

Earnings

Latest Release
26-03-2026
EPS / Forecast
-23.02 / -0.10
Revenue / Forecast
384.81M / 357.13M
EPS Revisions
Last 90 days

PIII Income Statement

Compare PIII to Peers and Sector

Metrics to compare
PIII
Peers
Sector
Relationship
P/E Ratio
−0.6x−10.9x−0.5x
PEG Ratio
−0.01−0.030.00
Price/Book
−0.5x5.6x2.6x
Price / LTM Sales
0.1x0.9x3.1x
Upside (Analyst Target)
−22.0%35.3%55.1%
Fair Value Upside
Unlock15.3%7.2%Unlock

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
96.05K2.89%880.76K
Other Institutional Investors
2.23M67.16%20.44M
Public Companies & Retail Investors
993.67K29.95%9.11M
Total
3.32M100.00%30.43M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Chicago Pacific Founders42.40%14,06,88514,758
Leavitt Equity Partners10.74%3,56,2703,737

FAQ

What Is the P3 Health Partners (PIII) Share Price Today?

The P3 Health Partners share price today is 10.4900.

What is the current P3 Health Partners (PIII) share price and day range?

As of 20-05-2026, the P3 Health Partners share price is 10.4900, with a previous close of 10.4900. The share price has ranged from 9.3500 to 13.1000 today, while the 52-week range spans from 1.5200 to 14.3500.

What Is the P3 Health Partners Market Cap?

As of today, P3 Health Partners market cap is 75.9200M.

What Is the P3 Health Partners (PIII) Share Price Target?

The average 12-month share price target for P3 Health Partners is 8.5000, with a high estimate of 14 and a low estimate of 3. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and -18.97% Downside potential.

What Is P3 Health Partners's Earnings Per Share (TTM)?

The P3 Health Partners EPS (TTM) is -38.5363.

From a Technical Analysis Perspective, Is PIII a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What Stock Exchange Does P3 Health Partners Trade On?

P3 Health Partners is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for P3 Health Partners?

The stock symbol for P3 Health Partners is "PIII."

How Many Times Has P3 Health Partners Stock Split?

P3 Health Partners has split 1 times.

How Many Employees Does P3 Health Partners Have?

P3 Health Partners has 320 employees.

What Is the PIII Premarket Price?

PIII's last pre-market stock price is 10.0000. The pre-market share volume is 21,330.0000, and the stock has changed by -0.4900, or -4.6700%.

What Is the PIII After Hours Price?

PIII's last after hours stock price is 10.0000, the stock has changed by -0.4900, or -4.6700%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.